Skip To Content

Michel Lussier, CEO

Michel Lussier serves as Chief Executive Officer of Metronom Health, Inc. and is an advisor to other Fjord Ventures portfolio companies. Michel had a successful career in the medical industry, where he held role as co-founder, Managing director, President and Chairman  of companies like Celyad (Cardio3 BioSciences), Volcano, Novoste Corp.

Prior to Novoste, Michel founded and led the European subsidiary of InControl Corp., until its acquisition by Guidant Corporation. He brings 15 years of operational experience with Medtronic, Inc., where he drove the company's core business in Europe as Business Director, Cardiac Pacing. Additionally, Michel holds a director mandate in Medpole S.A. and has chaired a number of committees within Eucomed, as well as serving on several start-up boards for medical devices. 

Michel received a B.S. in Electrical Engineering and an M.S. in Biomedical Engineering from the University of Montreal, Canada, and an M.B.A. from INSEAD, France.


You are now leaving the website of Metronom Health, Inc. and entering a third-party website over which Metronom Health, Inc. has no control. Neither Metronom Health, Inc. nor its subsidiaries or affiliates, are responsible for the content of third-party websites hyperlinked from this page or any hyperlink contained in a hyperlinked website, nor do they guarantee or endorse the information, recommendations, products or services offered on third-party websites.

Continue Cancel